Continuous infusion of coagulation factors
- 16 May 2002
- journal article
- review article
- Published by Wiley in Haemophilia
- Vol. 8 (3) , 170-177
- https://doi.org/10.1046/j.1365-2516.2002.00635.x
Abstract
Summary. Continuous infusion (CI) of coagulation factor concentrate is aimed at maintaining a steady haemostatic level of the missing factor in circulation, preventing dangerous troughs below the ha...Keywords
This publication has 41 references indexed in Scilit:
- Reconstituted recombinant factor VIII can be safely infused continuously for at least three daysBlood Coagulation & Fibrinolysis, 1998
- Liver failure and mortality in HIV‐positive haemophiliacs: FOURTEEN‐YEAR EXPERIENCE AND LITERATURE REVIEWHaemophilia, 1997
- Dosing and Monitoring NovoSeven® TreatmentPathophysiology of Haemostasis and Thrombosis, 1996
- The successful removal of a bleeding intracranial tumour in a severe haemophiliac using an adjusted dose continuous infusion of monoclonal factor VIIIBlood Coagulation & Fibrinolysis, 1995
- Stability of factor VIII concentrates after reconstitutionAmerican Journal of Hematology, 1994
- Continuous infusion of monoclonal antibody-purified factor VIII: Rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIIIAmerican Journal of Hematology, 1994
- Treatment with a pure factor IX concentrate in a patient with moderate hemophilia B undergoing bilateral total hip replacementTransfusion, 1993
- The use of continuous infusion of factor concentrates in the treatment of hemophiliaAmerican Journal of Hematology, 1989
- Continuous Intravenous Infusion of Factor VIII in Classic HaemophiliaBritish Journal of Haematology, 1970